静脉注射胺碘酮治疗急性心肌梗死伴发快速心房纤颤

首都医科大学学报 ›› 2002, Vol. 23 ›› Issue (3): 222-224.

静脉注射胺碘酮治疗急性心肌梗死伴发快速心房纤颤

宋柯, 刘玄重

首都医科大学附属北京天坛医院心内科

收稿日期:2001-10-29 修回日期:1900-01-01 出版日期:2002-07-15 发布日期:2002-07-15

Intravenous Amiodarone for Fast Atrial Fibrillation in Patients with Acute Myocardial Infarction

Song Ke, Liu Xuanzhong

Department of Cardiology, Beijing Tiantan Hospital, Affiliate of Capital University of Medical Sciences

Received:2001-10-29 Revised:1900-01-01 Online:2002-07-15 Published:2002-07-15

摘要/Abstract

摘要： 为观察静脉注射胺碘酮对急性心肌梗死(AMI)伴发快速心房纤颤(简称房颤)患者的临床疗效,对48例AMI伴新近发生快速房颤患者,静脉应用胺碘酮,观察房颤转复、心室率控制情况及不良反应.结果显示,48例患者用药后15min、30min、1h、6h、24h心室率分别为(107.17±9.67)次/min,(96.00±8.39)次/min,(88.13±9.98)次/min,(79.88±10.19)次/min,(74.88±9.80)次/min,较用药前的(130.58±9.15)次/min明显下降.48例患者在24h内均转为窦性心律,3例出现窦缓,1例为窦缓+Ⅱ度Ⅱ型房室传导阻滞.提示静脉应用胺碘酮治疗AMI并发的快速房颤是有效和安全的.

关键词: 胺碘酮, 急性心肌梗死, 心房纤颤

Abstract: To determine the clinical efficacy of amiodarone in fast atrial fibrillation in patients with acute myocardial infarction, 48 acute myocardial infarction patients with recent onset of fast atrial fibrillation were observed. After an intravenous load, intravenous amiodarone was administered continuously. Efficacy of amiodarone in the reversion of atrial fibrillation and the control of ventricular rate as well as the side effects were observed. The ventricular rates of 15 min, 30 min, 1 h, 6 h, 24 h after the administration of amiodarone in the 48 patients were(107.17±9.67)beats/min,(96.00± 8.39)beats/min,(88.13±9.98)beats/min,(79.88±10.19)beats/min,(74.88±9.80)beats/min respectively, which were lower than the rate(130.58±9.15)beats/min before the drug was given. Atrial fibrillation was reverted to sinus rhythm within 24 h in 48 cases. Sinus bradycardia was observecd in 3 patients. Sinus bradycardia and Ⅱ°Ⅱ type AVB occurred in 1 patient. Intravenous amiodarone is effective and safe in the treatment of fast atrial fibrillation in patients with AMI.

Key words: amiodarone, acute myocardial infarction, atrial fibrillation

中图分类号:

宋柯;刘玄重. 静脉注射胺碘酮治疗急性心肌梗死伴发快速心房纤颤[J]. 首都医科大学学报, 2002, 23(3): 222-224.

Song Ke;Liu Xuanzhong . Intravenous Amiodarone for Fast Atrial Fibrillation in Patients with Acute Myocardial Infarction[J]. Journal of Capital Medical University, 2002, 23(3): 222-224.

[1]	苏文, 李虹伟, 陈晖, 李卫萍. 急性心肌梗死患者D二聚体质量浓度与远期预后的关系[J]. 首都医科大学学报, 2022, 43(2): 173-177.
[2]	鲍博艺, 李卫萍. 外泌体miRNA在急性心肌梗死中的研究进展[J]. 首都医科大学学报, 2022, 43(2): 199-204.
[3]	王长华;陈韵岱;杨新春;王乐丰;王红石;孙志军;刘宏斌;陈练. 女性患者急诊冠状动脉介入后无复流的独立预测因素[J]. 首都医科大学学报, 2012, 33(4): 432-436.
[4]	丁顺晶;李燕. 小剂量重组组织型纤维溶酶原激活剂治疗急性心肌梗死的疗效观察[J]. 首都医科大学学报, 2010, 31(2): 280-281.
[5]	徐洪涛;高连如;张宁坤;朱智明;费宇行;杨晔;王兆君;刘英明;曹毅;陈宇;李贤峰. 急性心肌梗死患者骨髓单核细胞移植前后血浆尾加压素和内皮素水平的变化[J]. 首都医科大学学报, 2010, 31(1): 99-102.
[6]	仇盛蕾;金玫;朱天刚;权欣;梁燕;史大卓;李永强;易京红;刘红旭. 益气养阴活血法对103例患者急性心肌梗死再灌注后心肌微循环的影响[J]. 首都医科大学学报, 2009, 30(4): 426-429.
[7]	杨敬;华琦;徐东;谭静. 高敏C反应蛋白在急性冠脉综合征中的临床意义[J]. 首都医科大学学报, 2009, 30(4): 556-559.
[8]	符浩;华琦;赵玉生. 小于60岁女性急性心肌梗死患者危险因素及预后的研究[J]. 首都医科大学学报, 2008, 29(5): 636-639.
[9]	范振兴;华琦;谭静;刘荣坤. IL-6和黏附分子对急性ST段抬高心肌梗死患者住院期间死亡的预测作用[J]. 首都医科大学学报, 2008, 29(4): 493-496.
[10]	李博宇;华琦. 绝经期前、后女性急性心肌梗死患者临床特点分析[J]. 首都医科大学学报, 2008, 29(2): 215-217,.
[11]	高敬;华琦;桑城;范振兴;王彩荣. 1 137例急性心肌梗死患者临床表现及超声心动图特点[J]. 首都医科大学学报, 2006, 27(5): 657-659.
[12]	路亚枫;胡大一;翟艳苓. 急性心肌梗死患者直接PCI前后血浆TF、TFPI水平的变化及其临床意义[J]. 首都医科大学学报, 2005, 26(4): 457-459.
[13]	许骥;华琦;刘力松;万云高;李东宝;胥照平;姜燕;杨旭;李天德;胡大一;刘荣坤;杨峥. 重组人尿激酶原与尿激酶对急性心肌梗死患者纤溶系统影响的比较[J]. 首都医科大学学报, 2005, 26(2): 132-135.
[14]	马淑;郝恒剑;秦明照;许毓申. 年轻急性心肌梗死患者的临床特征[J]. 首都医科大学学报, 2004, 25(4): 479-481.
[15]	高永红;石浩. 急性下壁心肌梗死伴胸前导联ST段压低与冠状动脉病变的关系及临床意义[J]. 首都医科大学学报, 2003, 24(2): 144-146.